Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Eyob Adane"'
Pharmacokinetic modeling of the blood‐stable camptothecin analog AR‐67 in two different formulations
Publikováno v:
Biopharmaceutics & Drug Disposition. 40:265-275
AR-67 is a lipophilic camptothecin analog currently under clinical investigation using a Cremophor EL based formulation. However, as potential toxicity limitations exist in the clinical use of Cremophor, an alternative cyclodextrin (SBE-β-CD) based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c26850cc114863f536cbf845a717535
https://doi.org/10.1002/bdd.2199
https://doi.org/10.1002/bdd.2199
Autor:
Nicolas Simon, Pieter Colin, Dolores Santos-Buelga, Karel Allegaert, Michael J. Dolton, Michel Struys, Alison H. Thomson, Daniel J. Touw, Jason A. Roberts, Fabio Silvio Taccone, Ana Martín-Suárez, Matthijs de Hoog, Emilia Barcia, Masato Yamamoto, Lo Yl, Douglas J. Eleveld, Eyob Adane
Publikováno v:
Clinical Pharmacokinetics, 58(6), 767-780. Adis
Clinical Pharmacokinetics, 58(6), 767-780. Springer International Publishing AG
Clinical Pharmacokinetics
Clinical Pharmacokinetics, Springer Verlag, 2019, 58 (6), pp.767-780. ⟨10.1007/s40262-018-0727-5⟩
Clinical pharmacokinetics, 58 (6
CLINICAL PHARMACOKINETICS
Clinical Pharmacokinetics, 58(6), 767-780. Springer International Publishing AG
Clinical Pharmacokinetics
Clinical Pharmacokinetics, Springer Verlag, 2019, 58 (6), pp.767-780. ⟨10.1007/s40262-018-0727-5⟩
Clinical pharmacokinetics, 58 (6
CLINICAL PHARMACOKINETICS
Background and Objectives: Uncertainty exists regarding the optimal dosing regimen for vancomycin in different patient populations, leading to a plethora of subgroup-specific pharmacokinetic models and derived dosing regimens. We aimed to investigate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ba270c934ce37363a6f6e9c7e35d91e
https://doi.org/10.1007/s40262-018-0727-5
https://doi.org/10.1007/s40262-018-0727-5
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 76(Supplement_1)
Purpose Results of a study to reduce the number of medication order-entry alerts and perceived alert fatigue by optimizing alert logic are reported. Methods Data on dosage alerts registered throughout a health system over 2 days per study phase (prei
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4261d0e2bcb2c2405e02da0bb2049fa4
https://pubmed.ncbi.nlm.nih.gov/30753316
https://pubmed.ncbi.nlm.nih.gov/30753316
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 22(2)
Pemetrexed (Alimta®) is a novel anti-folate antimetabolite agent that is used in combination with cisplatin for the treatment of patients with unresectable malignant pleural mesothelioma and as a single agent or in combination with cisplatin for pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec795ff5fbbd0a95ffb39d57b251adea
https://pubmed.ncbi.nlm.nih.gov/25908647
https://pubmed.ncbi.nlm.nih.gov/25908647
Publikováno v:
Journal of Clinical Oncology. 32:6-6
6 Background: Breast cancer is the most common cancer in females. Screening mammogram has been linked to reduced breast cancer mortality through early detection and effective treatment following diagnosis. Despite the dramatic improvement in the use
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa47baa9e2f4133d513398a152bef263
https://doi.org/10.1200/jco.2014.32.26_suppl.6
https://doi.org/10.1200/jco.2014.32.26_suppl.6
Publikováno v:
Journal of Clinical Oncology. 32:e12019-e12019
e12019 Background: Cigarette smoking enhances reactions of normal tissues such as the oral mucosa, larynx and lungs to radiation exposure. The effect of smoking on the severity of acute skin reacti...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b712546827398368f2bb4e0fb4f3807
https://doi.org/10.1200/jco.2014.32.15_suppl.e12019
https://doi.org/10.1200/jco.2014.32.15_suppl.e12019
Publikováno v:
Journal of Clinical Oncology. 31:e14673-e14673
e14673 Background: Colorectal cancer is the third most common cancer worldwide. Smoking has been increasingly reported as a risk factor. Poorly differentiated adenocarcinoma in colorectal cancer has been reported to have a worse outcome. Poorly and m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ace86590cb8477e58c9dd72cea5ae2ae
https://doi.org/10.1200/jco.2013.31.15_suppl.e14673
https://doi.org/10.1200/jco.2013.31.15_suppl.e14673